Why Novavax Stock Is Up Big Yet Again Today
Shares of the developmental-stage vaccine company Novavax (NASDAQ: NVAX) are gearing up for another strong session today. In premarket action Friday morning, the biotech's shares jumped by as much as 14.2%.
The spark? Novavax announced after the closing bell Thursday that the U.S. Department of Defense (DoD) had awarded the company a handsome $60 million to fund the manufacturing of its experimental COVID-19 vaccine, NVX‑CoV2373. As part of the deal, Novavax will reportedly deliver 10 million doses of NVX-CoV2373 to the DoD later this year.
Image source: Getty Images.
Source Fool.com
